|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.01 USD | -0.52% |
|
-1.23% | +11.51% |
| 06-28 | Indivior Pharmaceuticals, Inc.(NasdaqGS:INDV) added to Russell 2000 Value-Defensive Index | CI |
| 06-28 | Indivior Pharmaceuticals, Inc.(NasdaqGS:INDV) added to Russell 2000 Growth-Defensive Index | CI |
| Market Cap | 4.9B 4.25B 3.96B 3.64B 6.87B 468B 6.98B 46.63B 18.33B 233B 18.41B 18.01B 772B | P/E 2026 * |
12.7x | P/E 2027 * | 11.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4.96B 4.3B 4B 3.68B 6.95B 473B 7.06B 47.15B 18.53B 236B 18.62B 18.21B 780B | EV / Sales 2026 * |
3.93x | EV / Sales 2027 * | 3.43x |
| Free-Float |
97.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 day | -0.52% | ||
| 1 week | -1.23% | ||
| Current month | -2.49% | ||
| 1 month | -2.49% | ||
| 3 months | +8.78% | ||
| 6 months | +13.09% | ||
| Current year | +11.51% |
| 1 week | 38.63 |  | 41.65 |
| 1 month | 38.56 | | 41.84 |
| Current year | 27.68 | | 42.81 |
| 1 year | 19.75 | | 42.81 |
| 3 years | 7.33 | | 42.81 |
| 5 years | 7.33 | | 42.81 |
| 10 years | 1.75 | | 42.81 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/10/26 | Sell | Chief Scientific Officer | -18,586 | 0.0152% | ||
| 5/13/26 | Free | Director | 6,518 | 0.0053% | ||
| 2/10/26 | Free | Executive/Senior Manager | 31,380 | 0.0251% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.52% | -1.23% | +129.94% | +75.71% | 4.9B | |
| -0.53% | -3.12% | +51.15% | +150.58% | 1,030B | |
| +0.21% | -1.13% | +53.26% | +46.92% | 617B | |
| -2.51% | -2.33% | +32.56% | +66.35% | 455B | |
| +0.06% | +1.17% | +36.21% | +31.25% | 350B | |
| -0.14% | -0.83% | +33.24% | +40.28% | 299B | |
| -0.69% | -0.44% | +9.86% | +14.23% | 265B | |
| -7.37% | -4.31% | -5.69% | -41.99% | 225B | |
| -0.64% | +3.68% | +27.80% | +62.95% | 209B | |
| -0.82% | -0.50% | +13.46% | +69.41% | 163B | |
| Average | -0.80% | +4.26% | +38.18% | +51.57% | 361.76B | |
| Weighted average by Cap. | -0.24% | +4.86% | +36.74% | +70.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.26B 1.09B 1.02B 935M 1.77B 120B 1.79B 11.98B 4.71B 59.86B 4.73B 4.63B 198B | 1.31B 1.14B 1.06B 974M 1.84B 125B 1.87B 12.48B 4.9B 62.35B 4.93B 4.82B 207B |
| Net income | 414M 360M 335M 307M 581M 39.53B 590M 3.94B 1.55B 19.69B 1.56B 1.52B 65.24B | 473M 410M 382M 351M 663M 45.1B 674M 4.5B 1.77B 22.46B 1.78B 1.74B 74.43B |
| Net Debt | 54.5M 47.28M 44M 40.43M 76.39M 5.2B 77.62M 518M 204M 2.59B 205M 200M 8.58B | -403M -350M -326M -299M -565M -38.48B -575M -3.84B -1.51B -19.16B -1.51B -1.48B -63.5B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | US$40.01 | -0.52% | 1,351,766 |
| 26-07-30 | US$40.22 | +0.30% | 1,580,952 |
| 26-07-29 | US$40.10 | -2.17% | 1,496,235 |
| 26-07-28 | US$40.99 | +2.40% | 1,778,428 |
| 26-07-27 | US$40.03 | -1.22% | 998,379 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
